DETECTION AND SUSCEPTIBILITY TESTING FOR …

— ≥ 80% risk over lifetime vs. ≤ 15% for immunocompetent hosts. b. ( risk of progressive 1° disease but reactivation still more common. c. (( incidence of extrapulmonary disease (50% vs. 15%) d. Lack of inflammatory response ( cavitary pulmonary disease much less common ................
................